APA (7th ed.) Citation

A, D., S, S., F, M., M, M., J, N., A, C., . . . S, H. (2022). SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: Study protocol of the prospective, observational CoCo immune study. BMC infectious diseases, 22(1), 403. https://doi.org/10.1186/s12879-022-07347-w

Chicago Style (17th ed.) Citation

A, Dopfer-Jablonka, et al. "SARS-CoV-2-specific Immune Responses in Elderly and Immunosuppressed Participants and Patients with Hematologic Disease or Checkpoint Inhibition in Solid Tumors: Study Protocol of the Prospective, Observational CoCo Immune Study." BMC Infectious Diseases 22, no. 1 (2022): 403. https://doi.org/10.1186/s12879-022-07347-w.

MLA (9th ed.) Citation

A, Dopfer-Jablonka, et al. "SARS-CoV-2-specific Immune Responses in Elderly and Immunosuppressed Participants and Patients with Hematologic Disease or Checkpoint Inhibition in Solid Tumors: Study Protocol of the Prospective, Observational CoCo Immune Study." BMC Infectious Diseases, vol. 22, no. 1, 2022, p. 403, https://doi.org/10.1186/s12879-022-07347-w.